These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 13902273)

  • 1. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
    GROSSET J; CANETTI G
    Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 4. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of drg-sensitivity tests on tubercle bacilli.
    Leat JL; Marks J
    Tubercle; 1970 Mar; 51(1):68-75. PubMed ID: 4099827
    [No Abstract]   [Full Text] [Related]  

  • 6. [DETERMINATION OF THE RESISTANCE OF TUBERCULOSIS BACTERIA IN THE SERIAL DILUTION TEST AND IN THE VERTICAL DIFFUSION TEST].
    KALICH R; GERLOFF W; KREBS A; SCHMIEDEL A
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1965 Jan; 129():353-69. PubMed ID: 14273020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 8. [NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
    SZENDROEI Z; CSERNUS A
    Magy Seb; 1964 Apr; 17():124-7. PubMed ID: 14152677
    [No Abstract]   [Full Text] [Related]  

  • 9. RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
    PFUETZE KH; PYLE MM
    JAMA; 1964 Mar; 187():805-10. PubMed ID: 14094316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Paper disk methods for determination of the drug sensitivity of Mycobacterium tuberculosis to the 2d order preparations. II].
    Afanas'eva IuP; Dorozhkova IR
    Lab Delo; 1969; 5():296-8. PubMed ID: 4185263
    [No Abstract]   [Full Text] [Related]  

  • 11. [PULMONARY TUBERCULOSIS MISDIAGNOSED AS OTHER DISEASES].
    SUGIYAMA K
    Rinsho Hoshasen; 1963 Dec; 8():919-20. PubMed ID: 14101293
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M; Suszko K
    Med Dosw; 1966; 33():291-302. PubMed ID: 4287506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 16. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apropos of resistance of Koch's bacillus to streptomycin, para-aminosalicylic acid, isonicotinoyl hydrazide and viomycin. Resistance of the organisms at the time of admission of the patient to the sanatorium].
    COX D
    Acta Tuberc Pneumol Belg; 1961; 52():206-13. PubMed ID: 13881889
    [No Abstract]   [Full Text] [Related]  

  • 18. [DRUG TREATMENT OF RENAL TUBERCULOSIS].
    TUOVINEN PI; SUTINEN S
    Suom Laakaril; 1964 Aug; 19():1629-38. PubMed ID: 14179990
    [No Abstract]   [Full Text] [Related]  

  • 19. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 20. MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
    WOLINSKY E
    Med Clin North Am; 1963 Sep; 47():1271-83. PubMed ID: 14062093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.